Kowarik, M.C.
Astling, D.
Lepennetier, G.
Ritchie, A.
Hemmer, B.
Owens, G.P.
Bennett, Jeffrey L. http://orcid.org/0000-0002-3346-1394
Funding for this research was provided by:
National Institutes of Health (R01EY022936)
DFG (EXC 2145 SyNergy, Ko 4367/1-1)
Novartis (Independent Research Grant)
This article is maintained by: Elsevier
Article Title: Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00975-7
Content Type: article
Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.